Company page

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. (ticker: HALO) is a public company based in the United States, with a market capitalization of approximately $8.24 billion. The company focuses on developing and commercializing innovative therapies for patients with unmet medical needs. Halozyme's proprietary technology platform is designed to enhance the delivery of biologic therapies.